Anterix Chief Legal Officer Ashe Gena L sold 4,357 shares at $85.44 per share in two transactions on 2026-09-08. The transactions left Ashe Gena L with 5,174 shares, giving investors the disclosed sale size and the officer’s remaining position.
Key Highlights
- Ashe Gena L is Anterix’s Chief Legal Officer and corporate secretary.
- Both transactions carried code S, denoting open-market sales.
- Ashe Gena L retained 5,174 Anterix shares after the transactions.
Anterix Inc. (NASDAQ: ATEX) Chief Legal Officer Ashe Gena L sold 4,357 shares at $85.44 per share. The sale was completed through two transactions on 8 September 2026, leaving Ashe Gena L with 5,174 shares.
Ashe Gena L holds the roles of Chief Legal Officer and corporate secretary at Anterix. The combined activity covered 4,357 shares, with the disclosed price set at $85.44 for each share. The transactions were completed on 8 September 2026. The reported sale involved 4,357 shares in total rather than a single transaction entry. Ashe Gena L’s remaining position after the activity was 5,174 shares.
FAQs
Q: How many Anterix shares did Ashe Gena L sell?
A: Ashe Gena L sold 4,357 Anterix shares at $85.44 per share. The sale was split across two transactions on 8 September 2026.
Q: What does the Anterix ATEX share sale mean for investors?
A: The disclosed transaction identifies a sale by Anterix Chief Legal Officer Ashe Gena L. It also shows that 5,174 shares remained afterward.
Q: How many Anterix shares did Ashe Gena L retain?
A: After the reported sale, Ashe Gena L retained 5,174 Anterix shares. Ashe Gena L serves as Anterix’s Chief Legal Officer and corporate secretary.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.